...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Sub- $.50

Bought some more at $.47 this AM. Given that Ori converted at $1.08 and other shareholders are in at well over this is a bargain, imo.   I think the fact that the major shareholder is Chinese Based is a  drag on share price and makes it complicated to do a deal with a name Big pharma based in N.A. or Europe, not to mention the myriad of other issues mentioned here several times before. If they get something going on Covid great but I am not counting on it. I think they can do something with BTD and Eversana eventually. Just sitting tight now for what could be a long haul. They could sell for at least $200 million or so to someone else if it gets that desperate, hopefully.

Share
New Message
Please login to post a reply